Jump Financial, LLC Cti Biopharma Corp Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Oct 21, 2024	BUY	$4.2 - $6.01 $364,833 - $522,058	86,865 New	86,865 $364,000
Q1 2023 May 03, 2023	SELL	$4.2 - $6.01 $20,277 - $29,016	-4,828 Reduced 5.27%	86,865 $364,000
Q4 2022 Feb 13, 2023	BUY	$4.45 - $6.17 $259,007 - $359,118	58,204 Added 173.8%	91,693 $551,000
Q3 2022 Nov 07, 2022	SELL	$5.36 - $7.43 $402,182 - $557,502	-75,034 Reduced 69.14%	33,489 $195,000
Q2 2022 Aug 09, 2022	BUY	$3.55 - $6.27 $385,256 - $680,439	108,523 New	108,523 $648,000
Q1 2021 May 17, 2021	SELL	$2.68 - $3.8 $103,984 - $147,440	-38,800 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.48 - $3.8 $96,224 - $147,440	38,800 New	38,800 $125,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.